Background: Rubella virus infection during pregnancy is associated with adverse fetal outcomes and reproductive failures. In Ethiopia, little is known about the extent of the disease and rubella vaccination is not widely available.
Background
Rubella (also called German measles or three-day fever) is among the TORCH infections, which also include Toxoplasmosis, Other (syphilis, varicella-zoster, parvovirus B19), Cytomegalovirus (CMV), and Herpes infections (1) (2) (3) (4) . These infections are commonly characterized by their easily transmissible nature from mother to fetus during pregnancy and are also responsible for congenital anomalies and possibly stillbirths (3) (4) (5) . The rubella virus is an enveloped, single stranded, positive sense RNA virus belonging to the Togaviridae family (6) . The viral genome encodes for five proteins, three structural proteins (two glycoproteins, E1 and E2 and the capsid protein) and two non-structural proteins (p90 and p150). The E1 glycoprotein contains the antigenic determinants that induce major immune responses and a hemagglutination inhibiting and hemagglutination-neutralizing epitope (7, 8) .
Rubella is a contagious disease usually manifested by a mild fever and rash, mostly in young adults and children. However, it can cause a serious birth defect called congenital rubella syndrome (CRS) when a pregnant woman becomes infected, particularly during the first trimester (9) (10) (11) . The birth defects associated with CRS are ophthalmic, auditory, cardiac, and craniofacial.
Infants with CRS who survive the neonatal period may face serious developmental disabilities and have an increased risk for developmental delay, including autism (5, 9, 10) . Based on a 2015 World Health Organization (WHO) update, globally, over 100,000 babies are born with CRS every year (11) . The rate of congenital defects and spontaneous abortion due to rubella virus infection among fetuses can be estimated to 65-85 % when acquired during the first two months of gestation (8) . Despite these potentially devastating consequences, many developing countries, including Ethiopia, are yet to include control and prevention of rubella virus infection within their national health strategies (12) .
Both humoral and cell-mediated immunity develop following rubella virus infection. Although natural rubella infection generally confers lifelong immunity, rare cases of serologically confirmed re-infections after earlier infection (or immunization) have been reported (13) . Immunoglobulin (Ig) G and IgM antibodies are observed about 14-18 days after rubella infection, at about the time when the rash appears. Rubella IgM antibodies wane quickly and are usually undetectable after two months, whereas rubella IgG antibodies persist (14) . Serologic tests such as enzyme immunoassay (EIA) that have been calibrated against the WHO Ethiop. J. Health Dev. 2018;32 (3) international standard (RUB-1-94) are important tools to measure rubella specific IgG and IgM, and are considered convenient, sensitive, and accurate methods of screening for rubella virus infection (13, 15) . Currently, there is no specific treatment for rubella virus infection. However, the rubella virus infection can be prevented by vaccination which can be available either in monovalent formulation or more commonly in combinations with other vaccines such as with vaccines against measles (MR), measles and mumps (MMR), or measles, mumps and varicella (MMRV). Large-scale rubella vaccination campaigns in the last decade have significantly reduced rubella and associated CRS in many developed nations (11) .
In developed countries, the diagnosis of rubella virus is part of prenatal health assessment and also used for understanding the prevalence of the infection, which varies widely in different countries. In sub-Saharan Africa, the sero-positivity of prevalence of rubella virus ranges from 66% to 99% (16) . Due to socioeconomic and other factors, pregnant women in developing countries including Ethiopia generally do not undergo routine antibody screening for rubella virus infection (4, 17) . Although little is known about rubella epidemiology and the incidence of CRS in Africa, it has been estimated that 110,000 CRS cases occur each year during non-epidemic years in developing countries (15) .
In Ethiopia, despite measles case-based surveillance system, there is lack of a national screening program for rubella virus infection. Reports showed that rubella is endemic in Ethiopia (12, (18) (19) (20) . However, there is no documented data regarding the prevalence of rubella virus infection during pregnancy. Furthermore, rubella vaccine is not included in the Ethiopian national immunization programme. Thus, the aim of this study was to assess the sero-prevalence of the rubella virus infection and its associated risk factors among pregnant women who attend antenatal care (ANC) in two hospitals of Amhara Region, Northwest Ethiopia.
Methods

Study setting:
This hospital based study was conducted at the antenatal clinics of Debre Markos and Debre Tabor hospitals of Amhara region, Northwest Ethiopia. Debre Markos hospital is the main public hospital in East Gojjam situated in Debre Markos city, the capital of East Gojjam zone. Similarly, Debre Tabor hospital is the main public hospital in the South Gonder zone situated in Debre Tabor city. Both are district hospitals providing different services including antenatal care for pregnant women.
Study design and period:
A hospital based crosssectional study design was employed from March to June 2015.
Study participants: Study participant were recruited from pregnant women who were seeking services at the antenatal clinics of the two hospitals during the study period and who volunteered to participate in the study. Participants were recruited sequentially until the maximum sample size was achieved. A total of 401 pregnant women -200 from Debre Markos Hospital and 201 from Debre Tabor Hospital -were included in the study based on the following assumption; 50% prevalence, 5% marginal error, 95% confidence interval and 10% non-response rate. The calculated sample size was equally divided between the hospitals as they represent the wide range of two major districts of the Northwest Ethiopia.
Data collection and laboratory procedures:
Interviews were conducted using structured questionnaires to collect information on the socio-demographic characteristics and associated risk factors. Nurses were specifically trained on how to collect the data. About 5ml venous blood sample was collected from all study participants by medical laboratory professionals. Blood samples were centrifuged and serum was separated and stored at -20 0 C until centrally processed at Bahir Dar Regional Health Research Laboratory Center (BRHRLC) using Enzyme Immuno Assay (EIA) technique (rubella IgG and IgM EIA test kit, Linear Chemicals, Barcelona) according to the manufacturer's instructions.
Rubella sero-positivity was diagnosed by both rubella IgG and IgM Enzyme Immunoassay (EIA) test kits. The Kits are a solid phase enzyme immunoassay based on indirect principle for the qualitative and quantitative detection of IgG and IgM antibodies to rubella in human serum. The microwell plate is coated with rubella antigens. If the specimens contain IgG or IgM antibodies to rubella, they will bind to the antigens coated on the microwell plate to form immobilized antigen-rubella IgG or IgM antibody complexes. Consequently, substrate A and B are added to produce a color that is measured at 4540nm with a microplate reader. The sensitivity and specificity of rubella IgG EIA test kit is 96.4% and >99.0% respectively. Similarly, the sensitivity and specificity of rubella IgM test kit is 90.0% and 94.9% respectively.
Data analysis: Data entry was conducted using Epi Data 3.1 and analysis was performed using SPSS, Version 21 (IBM-SPSS Inc) software. The sociodemographic characteristics of the study participants were summarized by proportions and categorical data were compared by Pearson's Chi-square. Binary and multivariable logistic regression analyses were used to assess factors associated with the rubella virus infection and at95% confidence interval. Statistical significance was set to P-value < 0.05.
Results
The mean age of study participants was 26.4 (SD= 5.4), with a majority (74.8%) of participants being urban dwellers (Table 1) . Based on EIA for rubella virus the overall sero-prevalence of rubella anti-IgG was 46.4% and the sero-prevalence of anti-IgM within IgG sero-positive was 3.2%. Although it was not statistically significant, the IgG sero-prevalence of rubella virus was relatively higher among pregnant women from Debre Tabor hospital (Table 2) . Table 3 below, the bivariate logistic regression analysis shows that stage of pregnancy (OR=2.49, 95% CI= 1.14-5.42) and HIV-sero status (OR= 0.33, 95% CI= 0.15-0.76) were significantly associated with rubella virus sero-positivity. Pregnant women who were on their first trimester were about three times more likely to be positive for anti-rubella IgG compared to those women in their third trimester (AOR= 3.16, 95% CI= 1.36-7.36). Similarly, those pregnant women with HIV infection were found to be about five times (AOR=5.14, 95% CI= 1.94-13.57) more likely to be positive for rubella virus infection (Table 3) . However, the association between rubella virus sero-positivity and other factors like gravidity, source of drinking water, history of spontaneous abortion, history of neonatal death, history of premature delivery, alcohol consumption, and history of reproductive tract infection and history of other chronic diseases other than HIV/AIDS were found to be statistically insignificant (p>0.05). (17, 24) , in Egypt (87.3%) (22) and in Sudan (95.1%) (25) which were notably higher prevalence compared to the findings in this study.
Though there is substantial transmission of rubella virus in the study area, our results show that the majority of the study participants (53.6%) were not immune against rubella virus. The lower sero-prevalence of anti-rubella IgG in this study might be linked with the absence of rubella vaccination in the national vaccination campaign.
As there is no surveillance programme of rubella virus infection and CRS in the country, it is important to determine the risk and level of CRS to determine the need for introduction of rubella vaccination especially during early in life.
Though it is not statistically significant, our study reported that there was an increased proportion of anti-rubella IgG sero-positivity as the age of pregnant mothers' increases. This finding is found to be consistent with the study reported from Nigeria and Burkina Faso (17, 26) . The relationship between HIV and rubella virus is poorly understood. In our study HIV sero-status was found to be significantly associated with rubella sero-positivity. Thus, further study with strong statistical power and longitudinal design is recommended to understand the relationship between these two infections.
A potential limitation of this study is the temporal relationship that may be interpreted because of its crosssectional design. The use of nurses in the ANC as data collectors may have also introduced desirability bias. The absence of association between various risk factors and rubella virus might be because the study did not have strong statistical power to detect the differences. This study overlooked the importance of including clinical data, outcome of the pregnancy and the sero-positivity of the newly born babies which would have been a good opportunity to describe the clinical presentation and the consequences of rubella virus infection during pregnancy on the newborn.
Conclusion and Recommendation:
In this study, the rubella virus sero-prevalence was found to be low as compared to other similar studies. On the contrary, susceptibility to rubella virus infection is believed to be very high in the study areas the pregnant women were all unvaccinated. In order to better understand the burden and epidemiology of rubella and CRS, the Ethiopian Ministry of Health may consider adopting a comprehensive approach to surveillance, establishing sentinel surveillance for CRS, and conducting appropriate studies to assist in defining the rubella susceptibility profile in school-aged girls and women of childbearing age. Information from such studies will be useful in the consideration of appropriate rubella control strategies in Ethiopia. 
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